Envoy Medical, Inc.
About Envoy Medical, Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $241.0K
- Net income
- -$23.8M
- Total assets
- $8.6M
- Market cap
- $50.8M
- Gross margin
- -262.7%
- Operating margin
- -9240.7%
- Net margin
- -9857.3%
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $241.0K
- Cost of revenue
- $874.0K
- Gross profit
- -$633.0K
- Operating expenses
- $21.6M
- Operating income
- -$22.3M
- Net income
- -$23.8M
- EPS (basic)
- $-1.23
- EPS (diluted)
- $-1.23
Balance sheet
- Total assets
- $8.6M
- Current assets
- $6.3M
- Total liabilities
- $20.3M
- Current liabilities
- $11.6M
- Shareholders’ equity
- -$12.2M
Cash flow
- Operating cash flow
- -$18.2M
- Investing cash flow
- -$179.0K
- Financing cash flow
- $16.6M
- Net cash flow
- -$1.7M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $50.8M
- EPS (diluted)
- $-1.23
- Shares outstanding
- 77.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 2, 2023
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $23.8M in FY2025.
- Revenue declined 24% from FY2023 to FY2025.
- Gross margin of -262.7%, net margin -9857.3%.
- Trading 62% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review Envoy Medical, Inc..
Write a review
News about Envoy Medical, Inc.
News & sentiment via Polygon.io
